Article Details
Retrieved on: 2022-03-01 16:53:18
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... did not receive monoclonal antibodies, efficacy was maintained, with a difference of −5.81 percent (relative risk reduction, 88.9 percent).
Article found on: consumer.healthday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here